DUPIXENT (& DESSIN)

View On IC.GC.CA

REGISTERED

on 5 Jul 2019

Last Applicant/ Owned by

SANOFI BIOTECHNOLOGY SOCIÉTÉ ANONYME

54 rue La Boétie75008, Paris

Serial Number

1811132 filed on 24^th Nov 2016

Registration Number

TMA1036528 registered on 5^th Jul 2019

Registration expiry Date

5^th Jul 2029

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

DUPIXENT (& DESSIN)

Trademark usage description

pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological dise Read More

Vienna Information

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

9 . 1 . 10

Ribbons, bowsRubans, noeuds

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, inflammatory pelvic diseases, respiratory diseases and disorders.

Classification kind code

Mark Details

Serial Number

1811132

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 25^th May 2018	Allowed
Submitted for opposition 51 on 25^th May 2018	Allowance Notice Sent
Submitted for opposition 42 on 7^th Feb 2018	Advertised
Submitted for opposition 26 on 18^th Jan 2018	Approved
Submitted for opposition 27 on 29^th Nov 2017	Approval Notice Sent
Submitted for opposition 22 on 17^th Oct 2017	Search Recorded
Submitted for opposition 20 on 17^th Oct 2017	Examiner's First Report
Submitted for opposition 31 on 28^th Nov 2016	Formalized
Submitted for opposition 1 on 25^th Nov 2016	Created
Submitted for opposition 30 on 24^th Nov 2016	Filed